Literature DB >> 27030122

Extracellular ATP protects endothelial cells against DNA damage.

Joonas Aho1, Mikko Helenius2, Sanna Vattulainen-Collanus2, Tero-Pekka Alastalo3, Juha Koskenvuo1,4.   

Abstract

Cell damage can lead to rapid release of ATP to extracellular space resulting in dramatic change in local ATP concentration. Evolutionary, this has been considered as a danger signal leading to adaptive responses in adjacent cells. Our aim was to demonstrate that elevated extracellular ATP or inhibition of ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD1/CD39) activity could be used to increase tolerance against DNA-damaging conditions. Human endothelial cells, with increased extracellular ATP concentration in cell proximity, were more resistant to irradiation or chemically induced DNA damage evaluated with the DNA damage markers γH2AX and phosphorylated p53. In our rat models of DNA damage, inhibiting CD39-driven ATP hydrolysis with POM-1 protected the heart and lung tissues against chemically induced DNA damage. Interestingly, the phenomenon could not be replicated in cancer cells. Our results show that transient increase in extracellular ATP can promote resistance to DNA damage.

Entities:  

Keywords:  ATP; CD39; Cancer; DNA damage; Endothelial cell; NTPDase1

Mesh:

Substances:

Year:  2016        PMID: 27030122      PMCID: PMC5023623          DOI: 10.1007/s11302-016-9508-5

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  35 in total

Review 1.  Cardiovascular toxicity caused by cancer treatment: strategies for early detection.

Authors:  Renske Altena; Patrick J Perik; Dirk J van Veldhuisen; Elisabeth Ge de Vries; Jourik A Gietema
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

2.  Chronic hypoxia impairs extracellular nucleotide metabolism and barrier function in pulmonary artery vasa vasorum endothelial cells.

Authors:  Gennady G Yegutkin; Mikko Helenius; Elzbieta Kaczmarek; Nana Burns; Sirpa Jalkanen; Kurt Stenmark; Evgenia V Gerasimovskaya
Journal:  Angiogenesis       Date:  2011-09-16       Impact factor: 9.596

3.  Purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

4.  Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species.

Authors:  Ebba U Kurz; Pauline Douglas; Susan P Lees-Miller
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

Review 5.  Cardiac complications of thoracic irradiation.

Authors:  Catherine Jaworski; Justin A Mariani; Greg Wheeler; David M Kaye
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

6.  Sustained adenosine exposure causes lung endothelial apoptosis: a possible contributor to cigarette smoke-induced endothelial apoptosis and lung injury.

Authors:  Qing Lu; Pavlo Sakhatskyy; Julie Newton; Paul Shamirian; Vivian Hsiao; Sean Curren; Gustavo Andres Gabino Miranda; Mesias Pedroza; Michael R Blackburn; Sharon Rounds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

Review 7.  DNA DSB repair pathway choice: an orchestrated handover mechanism.

Authors:  A Kakarougkas; P A Jeggo
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

8.  EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma.

Authors:  Bipasha Mukherjee; Brian McEllin; Cristel V Camacho; Nozomi Tomimatsu; Shyam Sirasanagandala; Suraj Nannepaga; Kimmo J Hatanpaa; Bruce Mickey; Christopher Madden; Elizabeth Maher; David A Boothman; Frank Furnari; Webster K Cavenee; Robert M Bachoo; Sandeep Burma
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

9.  Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor.

Authors:  R B Montgomery; D K Moscatello; A J Wong; J A Cooper; W L Stahl
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

10.  Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells.

Authors:  Evgenia V Gerasimovskaya; Heather N Woodward; Doug A Tucker; Kurt R Stenmark
Journal:  Angiogenesis       Date:  2007-12-11       Impact factor: 9.596

View more
  5 in total

1.  The P2-receptor-mediated Ca2+ signalosome of the human pulmonary endothelium - implications for pulmonary arterial hypertension.

Authors:  Jan K Hennigs; Nicole Lüneburg; Annett Stage; Melanie Schmitz; Jakob Körbelin; Lars Harbaum; Christiane Matuszcak; Julia Mienert; Carsten Bokemeyer; Rainer H Böger; Rainer Kiefmann; Hans Klose
Journal:  Purinergic Signal       Date:  2019-08-08       Impact factor: 3.765

2.  Modulation of Cardiopulmonary Toxicity and Oxidative Stress by Phenolic-Rich Fraction of Croton zambiscus Leaves in Rat Exposed to Chronic Mixture of Environmental Toxicants.

Authors:  J K Akintunde; G O Oyedibu; N J Olanipekun; O A Olaleye
Journal:  Cardiovasc Toxicol       Date:  2020-11-01       Impact factor: 3.231

3.  A mechanism for semaphorin-induced apoptosis: DNA damage of endothelial and myogenic cells in primary cultures from skeletal muscle.

Authors:  Haynes Shek Hei Yuan; Sachin Katyal; Judy E Anderson
Journal:  Oncotarget       Date:  2018-04-27

4.  Increased Purinergic Responses Dependent on P2Y2 Receptors in Hepatocytes from CCl4-Treated Fibrotic Mice.

Authors:  Erandi Velázquez-Miranda; Christian Molina-Aguilar; Adriana González-Gallardo; Olivia Vázquez-Martínez; Mauricio Díaz-Muñoz; Francisco G Vázquez-Cuevas
Journal:  Int J Mol Sci       Date:  2020-03-26       Impact factor: 5.923

Review 5.  P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.

Authors:  Derek Strassheim; Alexander Verin; Robert Batori; Hala Nijmeh; Nana Burns; Anita Kovacs-Kasa; Nagavedi S Umapathy; Janavi Kotamarthi; Yash S Gokhale; Vijaya Karoor; Kurt R Stenmark; Evgenia Gerasimovskaya
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.